On May 3, 2023 Australia’s TGA announced they were removing the ‘off-label” use prescribing restrictions from ivermectin “because there is sufficient evidence that the safety risks to individuals and public health is low when prescribed by a general practitioner in the current health climate.” TGA enacted the ban on September 10, 2021 but due to a “sharp rise in prescriptions”. [1, 2]
The removal comes into effect June 1, 2023 but TGA still discourages off-label prescribing of ivermectin for COVID-19, no mention of its use in treating vaccine injury.